LawPlayer
My bookmarksSign up freeSign up free
Source

2012/362/EU: Commission Implementing Decision of 4 July 2012 concerning a financial contribution by the Union to certain Member States to support voluntary surveillance studies on honeybee colony losses (notified under document C(2012) 4396)

2012/362/EU: Commission Implementing Decision of 4 July 2012 concerning a financial contribution by the Union to certain Member States to support voluntary surveillance studies on honeybee colony losses (notified under document C(2012) 4396)

Decision · 7 articles

In forceLast amended 2013-05-22

Version history

  1. Superseded version
  2. In force

Data as of 2026-11-02 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

Open ↗

1.   The Union shall grant Belgium, Denmark, Germany, Estonia, Greece, Spain, France, Italy, Latvia, Lithuania, Hungary, Poland, Portugal, Slovakia, Finland, Sweden and the United Kingdom financial assistance for their surveillance study programmes on honeybee colony losses. 2.   The financial contribution by the Union: (a)  shall be at the rate of 70 % of the eligible costs to be incurred by each Member State referred to in paragraph 1 for the surveillance study programmes on honeybee colony losses and specified in Annex I for the period from 1 April 2012 to  30 September 2013; (b)  shall not exceed the following: 1.  EUR 62 876 for Belgium; 2.  EUR 192 688 for Denmark; 3.  EUR 294 230 for Germany; 4.  EUR 66 637 for Estonia; 5.  EUR 109 931 for Greece; 6.  EUR 205 050 for Spain; 7.  EUR 529 615 for France; 8.  EUR 521 590 for Italy; 9.  EUR 147 375 for Latvia; 10.  EUR 92 123 for Lithuania; 11.  EUR 98 893 for Hungary; 12.  EUR 254 108 for Poland; 13.  EUR 28 020 for Portugal; 14.  EUR 183 337 for Slovakia; 15.  EUR 213 986 for Finland; 16.  EUR 39 862 for Sweden; 17.  EUR 267 482 for the United Kingdom. (c)  shall not exceed EUR 595 per visit of an apiary.

Article 2

Open ↗

1.   The maximum overall contribution authorised by this Decision for the costs incurred for the programmes referred to in Article 1 is set at EUR 3 307 803 to be financed from the general budget of the European Union. 2.   Expenditure relating to staff costs for performing laboratory tests, sampling, monitoring, consumables and overheads dedicated to the surveillance studies shall be eligible in accordance with the rules set out in Annex III. 3.   The Union’s financial assistance shall be paid following presentation and approval of the reports and supporting documents referred to Article 3(2) and (3).

Article 3

Open ↗

1.   The programmes shall be carried out in accordance with the technical document ‘Basis for a pilot surveillance project on honey bee colony losses’ (available at http://ec.europa.eu/food/animal/liveanimals/bees/bee_health_en.htm) and in accordance with the surveillance study programmes on honeybee colony losses presented by the Member States. 2.   Belgium, Denmark, Germany, Estonia, Greece, Spain, France, Italy, Latvia, Lithuania, Hungary, Poland, Portugal, Slovakia, Finland, Sweden and the United Kingdom shall submit to the Commission: —  no later than 1 March 2013 an intermediate technical report on the first visit provided for in the surveillance study programme, and —  no later than 31 October 2013 a final technical report on the second and third visits provided for in the surveillance study programme, —  the technical report should be in conformity to a model to be established by the Commission in cooperation with the EU reference laboratory for bee health. 3.   Belgium, Denmark, Germany, Estonia, Greece, Spain, France, Italy, Latvia, Lithuania, Hungary, Poland, Portugal, Slovakia, Finland, Sweden and the United Kingdom shall submit to the Commission: —  no later than 31 December 2013 a paper version and an electronic version of their financial report drawn up in accordance with Annex II. The supporting documents, evidencing all the expenditure referred to in the application for reimbursement, shall be sent to the Commission on request. 4.   The outcome of the studies shall be made available to the Commission and the EU reference laboratory for bee health.

Article 4

Open ↗

This Decision is addressed to the Kingdom of Belgium, the Kingdom of Denmark, the Federal Republic of Germany, the Republic of Estonia, the Hellenic Republic, the Kingdom of Spain, the French Republic, the Italian Republic, the Republic of Latvia, the Republic of Lithuania, Hungary, the Republic of Poland, the Portuguese Republic, the Slovak Republic, the Republic of Finland, the Kingdom of Sweden and the United Kingdom of Great Britain and Northern Ireland.

Supplementary provisions

ANNEX ISupplementary provisions

Open ↗

ANNEX I Member State Number of apiaries Number of visits per apiary foreseen in the surveillance study Total direct costs (Laboratory tests + visits for sampling and monitoring) Overheads (7 %) Total cost EU contribution (70 %) BE 150 3 83 946 5 876 89 822 62 876 DK 194 3 257 260 18 008 275 268 192 688 DE 220 3 392 831 27 498 420 329 294 230 EE 196 3 88 968 6 228 95 196 66 637 EL 200 3 146 770 10 274 157 044 109 931 ES 200 3 273 765 19 164 292 929 205 050 FR 396 3 707 096 49 497 756 593 529 615 IT 390 3 696 382 48 747 745 129 521 590 LV 193 3 196 762 13 773 210 535 147 375 LT 193 3 122 994 8 610 131 604 92 123 HU 196 3 132 034 9 242 141 276 98 893 PL 190 3 339 263 23 749 363 012 254 108 PT 145 3 37 410 2 619 40 029 28 020 SK 198 3 244 776 17 134 261 910 183 337 FI 160 3 285 695 19 999 305 694 213 986 SE 150 3 53 220 3 725 56 945 39 862 UK 200 3 357 119 24 998 382 117 267 482 Total     4 416 293 309 141 4 725 433 3 307 803

ANNEX IISupplementary provisions

Open ↗

ANNEX II MODEL FOR A FINANCIAL REPORT ON VOLUNTARY SURVEILLANCE STUDIES ON HONEYBEE COLONY LOSSES Total expenditure for the project (real costs, VAT excl.) Member State:   Number of apiaries visited: Laboratory costs Staff category Number of working days Daily rate Total …       …               Consumables (description) Quantity Unit cost Total …       …       Sampling and monitoring costs (apiary visits) Staff category Number of working days Daily rate Total …       …               Consumables (description) Quantity Unit cost Total …       …       Certification by the beneficiary We certify that: —  the expenditure listed above was incurred in the performance of tasks described in the technical document ‘Basis for a pilot surveillance project on honey bee colony losses’  ( 5 ) and directly related to the implementation of the surveillance study programme for which financial support was granted according to Commission Implementing Decision 2012/362/EU, —  the expenditure was actually incurred, accurately accounted for and eligible under the provisions of Implementing Decision 2012/362/EU, —  all supporting documents relating to the expenditure are available for auditing, —  no other Union contribution was requested for the projects listed in this Decision. Date: Name and signature of the financial officer responsible:

ANNEX IIISupplementary provisions

Open ↗

ANNEX III ELIGIBILITY RULES 1.    Laboratory costs —  Staff costs shall be limited to actual attributable labour costs (remuneration, wages, social charges and retirement costs) accrued in implementation of the study and performing laboratory tests. To this end monthly timesheets have to be maintained. —  Daily rate will be calculated on a 220 working days/year. —  Reimbursement of consumables shall be based on actual costs incurred by Member States to perform the tests at the laboratory. —  Test kits, reagents and all consumables shall only be reimbursed if used specifically in the performance of the following tests: —  varroa count (washing), —  detection and characterisation of deformed wing virus (DWV), the acute bee paralysis virus (ABPV), the small hive beetle ( Aethina tumida ) and the tropilaelaps mite), —  clinical observation (including symptom observation foulbrood, nosema, viruses) microsporidian parasite ( Nosema spp.) spore counts, cultures, microscopic examination and biochemical tests to identify the causal agent European foulbrood ( Melissococcus plutonius ) and American foulbrood (Paenibacillus larvae), —  American foulbrood — confirmation of the identity of the causal agent American foulbrood and European foulbrood via polymerase chain reaction (PCR). 2.    Sampling and monitoring costs —  Costs for sampling and monitoring can only be claimed it they are directly linked to visits of apiaries. —  Staff costs shall be limited to actual attributable labour costs (remuneration, wages, social charges and retirement costs) accrued in implementation of the study. To this end monthly timesheets have to be maintained. —  Daily rate will be calculated on a 220 working days/year. —  Reimbursement of consumables shall be based on actual costs incurred by Member States and shall only be reimbursed if used specifically during visits to the apiaries. 3.    Overheads A flat rate contribution of 7 % calculated on the basis of all direct eligible costs may be claimed. 4. The expenditure submitted by the Member States for a financial contribution by the Union shall be expressed in euro and shall exclude value added tax (VAT) and all other taxes.

Other acts of the same type
Council Decision (CFSP) 2022/157 of 4 February 2022 amending Council Decision (CFSP) 2017/1775 concerning restrictive measures in view of the situation in MaliCommission Implementing Decision (EU) 2022/162 of 4 February 2022 laying down rules for the application of Directive (EU) 2019/904 of the European Parliament and of the Council as regards the calculation, verification and reporting on the reduction in the consumption of certain single-use plastic products and the measures taken by Member States to achieve such reduction (Text with EEA relevance)Council Decision (CFSP) 2022/151 of 3 February 2022 on a European Union action to support the evacuation of certain particularly vulnerable persons from AfghanistanCouncil Decision (CFSP) 2022/153 of 3 February 2022 amending Decision 2011/486/CFSP concerning restrictive measures directed against certain individuals, groups, undertakings and entities in view of the situation in AfghanistanCouncil Decision (CFSP) 2022/154 of 3 February 2022 amending Decision 2011/72/CFSP concerning restrictive measures directed against certain persons and entities in view of the situation in TunisiaCommission Implementing Decision (EU) 2022/161 of 3 February 2022 terminating the examination procedure concerning obstacles to trade within the meaning of Regulation (EU) 2015/1843 applied by the United Mexican States consisting of measures affecting the import of TequilaPolitical and Security Committee Decision (CFSP) 2022/164 of 3 February 2022 on the activation of the European Union military operation to contribute to the deterrence, prevention and repression of acts of piracy and armed robbery off the Somali coast (Atalanta)’s secondary executive task of contributing to countering narcotic drugs trafficking off the coast of Somalia (ATALANTA/2/2022)Commission Implementing Decision (EU) 2022/171 of 2 February 2022 on the request for registration of the European citizens’ initiative entitled ‘Win It On The Pitch’ pursuant to Regulation (EU) 2019/788 of the European Parliament and of the Council (notified under document C(2022) 630) (Only the English text is authentic)Commission Implementing Decision (EU) 2022/146 of 1 February 2022 determining whether a product containing Alkyl (C12-16) dimethylbenzyl ammonium chloride is a biocidal product, pursuant to Article 3(3) of Regulation (EU) No 528/2012 of the European Parliament and of the Council (Text with EEA relevance)Commission Implementing Decision (EU) 2022/142 of 31 January 2022 amending Implementing Decision (EU) 2019/1741 as regards the reporting on production volume and correcting that Implementing Decision (notified under document C(2022) 451) (Text with EEA relevance)Commission Implementing Decision (EU) 2022/155 of 31 January 2022 concerning the extension of the action taken by the Health and Safety Executive of the United Kingdom permitting the making available on the market and use of the biocidal product Clinisept + Skin Disinfectant in accordance with Article 55(1) of Regulation (EU) No 528/2012 of the European Parliament and of the Council (notified under document C(2022)457) (Only the English text is authentic)Commission Implementing Decision (EU) 2022/137 of 28 January 2022 concerning the extension of the action taken by the Health and Safety Executive of the United Kingdom permitting the making available on the market and use of the biocidal product Mydis in accordance with Article 55(1) of Regulation (EU) No 528/2012 of the European Parliament and of the Council (notified under document C(2022) 408) (Only the English text is authentic)

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next